What pitfalls should be considered when diagnosing brain death in children, including age >36 weeks post‑conception, core temperature, metabolic/electrolyte abnormalities, central nervous system‑depressant drug effects, hypoxia, hypotension, hypercapnia, seizures, and congenital brain malformations?

Pitfalls in Diagnosing Brain Death in Children

The most critical pitfalls in pediatric brain death determination involve failing to exclude reversible confounders before examination, particularly hypothermia (core temperature <35°C), hypotension, metabolic/electrolyte derangements, and CNS-depressant drug effects—all of which must be corrected prior to any brain death evaluation. 1

Prerequisites That Must Be Corrected Before Examination

Temperature Requirements

• Core body temperature must be ≥35°C (95°F) before proceeding with brain death evaluation 1
• Hypothermia can mimic brain death by suppressing neurologic function and must be actively corrected

Hemodynamic Stability

• Hypotension must be treated and corrected before examination 1
• Inadequate cerebral perfusion pressure can confound the clinical examination
• Ensure age-appropriate blood pressure is maintained

Metabolic and Electrolyte Abnormalities

• All metabolic disturbances must be corrected prior to brain death testing 1
• Severe electrolyte imbalances (particularly sodium, glucose, calcium) can alter neurologic responsiveness
• Hepatic encephalopathy, uremia, and other metabolic derangements must be excluded or corrected

Medication-Related Pitfalls

CNS-Depressant Drug Effects

This is one of the most common and dangerous pitfalls. Sedatives, analgesics, neuromuscular blockers, and anticonvulsant agents must be discontinued for adequate clearance time based on elimination half-lives 1

Key principles:

• Do NOT proceed with brain death examination if supratherapeutic or high therapeutic levels of sedative agents are present 1
• When drug levels are in low-to-mid therapeutic range, medication effects are unlikely to confound examination
• If uncertainty remains about drug effects, perform an ancillary study (EEG or cerebral blood flow) rather than relying on clinical examination alone 1
• Consider total cumulative dose (mg/kg) administered since admission, not just recent dosing 1

Age-Specific Pitfalls

Preterm Infants (<37 Weeks Gestational Age)

Brain death cannot be reliably determined in preterm infants <37 weeks post-conception due to insufficient data 1

• The guidelines explicitly exclude this population
• Do not attempt brain death determination in this age group

Term Newborns (37 Weeks to 30 Days)

• Ancillary studies (EEG and cerebral blood flow) are LESS sensitive in this age group 1
• Cerebral blood flow studies may be preferred over EEG in neonates 1
• Requires 24-hour observation period between examinations 1
• Only 63% of newborns with absent cerebral blood flow were correctly identified in one analysis 1

Timing-Related Pitfalls

Post-Resuscitation Period

Assessment should be deferred for 24-48 hours (or longer) following cardiopulmonary resuscitation or severe acute brain injury if there are concerns or inconsistencies in the examination 1

This is critical because:

• Neurologic function may be unreliable immediately post-arrest
• Allows time for medication clearance
• Permits stabilization of metabolic parameters
• Reduces risk of premature declaration

Inadequate Observation Periods

• Term newborns (37 weeks to 30 days): 24 hours between examinations 1
• Infants and children (>30 days to 18 years): 12 hours between examinations 1
• These intervals can only be shortened if ancillary studies confirm brain death 1

Examination-Related Pitfalls

Apnea Testing Errors

The apnea test must demonstrate PaCO₂ ≥60 mm Hg AND ≥20 mm Hg above baseline with no respiratory effort 1

Common mistakes:

• Failing to achieve adequate CO₂ stimulus (must reach both thresholds)
• Not accounting for chronic respiratory disease patients who may require higher baseline PaCO₂
• Proceeding despite hemodynamic instability or desaturation to <85% during testing
• If apnea test cannot be safely completed, an ancillary study is REQUIRED 1

Misinterpreting Spinal Reflexes

• Spinal reflexes can persist after brain death and should not be confused with brain-mediated responses 1
• Requires clinical expertise to differentiate spinal from cerebral motor responses
• Complex spinal automatisms can occur and do not preclude brain death diagnosis

Seizure-Related Pitfalls

While not explicitly detailed in the primary guidelines, nonconvulsive seizures can confound the examination 2

• Consider EEG if there is any suspicion of ongoing seizure activity
• Anticonvulsant levels must be in low-to-mid therapeutic range, not supratherapeutic 1
• If seizures are present or suspected, brain death cannot be declared on clinical grounds alone

Congenital Brain Malformation Considerations

Congenital brain malformations do not preclude brain death determination, but require careful consideration 3

• The key is establishing that there is an acute, irreversible cause of coma superimposed on the malformation
• Baseline neurologic function must be considered
• May require ancillary testing if baseline examination is uncertain
• Ensure the malformation itself is not the sole reason for absent reflexes

Ancillary Testing Pitfalls

When Ancillary Studies Are Indicated

Ancillary studies (EEG or cerebral blood flow) should be used when: 1

1. Components of examination or apnea testing cannot be safely completed
2. Uncertainty exists about neurologic examination results
3. Medication effects may be present
4. To reduce the observation period

Critical Caveat

Ancillary studies are NOT a substitute for the neurologic examination 1

• Even with ancillary testing, a second clinical examination must be performed
• All components that can be safely completed must remain consistent with brain death
• If ancillary study is equivocal, wait 24 hours and repeat evaluation 1

Procedural Pitfalls

Examiner Requirements

• Two different attending physicians must perform the examinations 1
• Both must be qualified and experienced in brain death determination
• The same physician may perform both apnea tests 1

Documentation Errors

• Failing to document all prerequisites were met
• Incomplete documentation of both examinations
• Not recording specific PaCO₂ values during apnea testing
• Missing documentation of medication clearance times

Special Populations

Hypoxic-Ischemic Encephalopathy

• May require longer observation periods
• Therapeutic hypothermia protocols complicate timing (newer 2023 guidelines address this more specifically 4, 5)
• Ensure adequate rewarming before examination

ECMO Patients

• Apnea testing modifications are required
• May need ancillary studies if standard testing cannot be performed safely
• Specific protocols exist in updated 2023 guidelines 4, 5

Common Misinterpretations Leading to Errors

Based on case reports 2:

• Declaring brain death despite normal cerebral blood flow on imaging
• Proceeding despite only localized (not global) brain injury on CT
• Inadequate waiting period after cardiac arrest
• Failing to recognize that normal fontanelle tension argues against global brain death in infants

The overarching principle: When in doubt, wait, correct confounders, and consider ancillary testing rather than rushing to declare brain death. The diagnosis requires absolute certainty of irreversible cessation of all brain function. 1